Published on 29 Mar 2018
Polarean Imaging PLC (LON:POLX) chief executive Richard Hullihen dropped
into the Proactive studio as the medtech firm kicked off its first day
of trading on AIM.
The company raised gross proceeds of £3mln via the placing of 20mln
ordinary shares at a price of 15p - representing 27.3% of the company’s
share capital.
Hullihen says the point of coming to the market was specifically to
raise the cash for their upcoming Phase III trials for their drug-device
technology.
http://www.londonstockexchange.com/exchange/prices-and-markets/stocks/new-and-recent-issues/new-recent-issue-details.html?issueId=9315
http://www.londonstockexchange.com/exchange/prices-and-markets/stocks/new-and-recent-issues/new-recent-issue-details.html?issueId=9315
No comments:
Post a Comment